Researchers at The University of Texas at Dallas’ Center for Advanced Pain Studies (CAPS) have uncovered a long-overlooked phenomenon that could revolutionize the understanding and treatment of diabetic neuropathy. Published in Nature Communications on May 5, the study highlights the role of cell clusters called Nageotte nodules in nerve cell death, offering a potential new target for therapies.
The study reveals that Nageotte nodules, first observed in rabbits a century ago but largely ignored since, are abundant in the sensory ganglia of individuals with diabetic neuropathy. These nodules consist of non-neuronal cells and are linked to nerve degeneration caused by high blood sugar levels. Notably, the researchers discovered sprouting pain-sensing fibers within the nodules, a previously undocumented feature in humans.
“This discovery forces us to rethink diabetic neuropathic pain,” said Dr. Ted Price, co-author and CAPS director. “Neurodegeneration in the dorsal root ganglion is a critical facet of the disease, and early neuroprotection could prevent these nodules from forming.”
Diabetic neuropathy affects nearly 11 million people in the U.S., often causing debilitating pain and limb damage. Current treatments are limited, but the identification of Nageotte nodules opens new avenues for drug development. “Targeting these structures could protect nerves or alleviate pain,” said lead researcher Stephanie Shiers.
The study, supported by the National Institutes of Health, analyzed tissue samples from 90 donors provided by the Southwest Transplant Alliance. “This partnership was essential to our work,” Price emphasized.
The findings challenge existing views of sensory neuron behavior and underscore the need for further research into neuroprotection strategies. By focusing on early intervention, scientists hope to mitigate the progression of diabetic neuropathy and improve patient outcomes.
Add comment